Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Accelerated SARS-CoV-2 intrahost evolution leading to distinct genotypes during chronic infection
Chrispin Chaguza, Anne M. Hahn, Mary E. Petrone, et al.
Cell Reports Medicine (2023) Vol. 4, Iss. 2, pp. 100943-100943
Open Access | Times Cited: 74

Showing 1-25 of 74 citing articles:

SARS-CoV-2 variant biology: immune escape, transmission and fitness
Alessandro M. Carabelli, Thomas P. Peacock, Lucy Thorne, et al.
Nature Reviews Microbiology (2023)
Open Access | Times Cited: 989
Prevalence of persistent SARS-CoV-2 in a large community surveillance study
Mahan Ghafari, Matthew Hall, Tanya Golubchik, et al.
Nature (2024) Vol. 626, Iss. 8001, pp. 1094-1101
Open Access | Times Cited: 74
Persistent SARS-CoV-2 infection: significance and implications
Heather Machkovech, Anne M. Hahn, Jacqueline Garonzik‐Wang, et al.
The Lancet Infectious Diseases (2024) Vol. 24, Iss. 7, pp. e453-e462
Open Access | Times Cited: 65
SARS-CoV-2 viral clearance and evolution varies by type and severity of immunodeficiency
Yijia Li, Manish C. Choudhary, James Regan, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 731
Open Access | Times Cited: 51
Numerical analysis of an advanced infrared-based graphene metasurface surface plasmon resonance sensor for COVID-19 detection
Jacob Wekalao, Abdullah Baz, Shobhit K. Patel
Diamond and Related Materials (2024), pp. 111601-111601
Closed Access | Times Cited: 23
Mutational signature dynamics indicate SARS-CoV-2’s evolutionary capacity is driven by host antiviral molecules
Kieran D. Lamb, Martha M. Luka, Megan Saathoff, et al.
PLoS Computational Biology (2024) Vol. 20, Iss. 1, pp. e1011795-e1011795
Open Access | Times Cited: 17
Contributions of adaptation and purifying selection to SARS-CoV-2 evolution
Richard A. Neher
Virus Evolution (2022) Vol. 8, Iss. 2
Open Access | Times Cited: 54
SARS-CoV-2 evolution during prolonged infection in immunocompromised patients
Andrew D. Marques, Jevon Graham-Wooten, Ayannah S. Fitzgerald, et al.
mBio (2024) Vol. 15, Iss. 3
Open Access | Times Cited: 12
Intra-Host Evolution Analyses in an Immunosuppressed Patient Supports SARS-CoV-2 Viral Reservoir Hypothesis
Dominique Fournelle, Fatima Mostefai, Elsa Brunet‐Ratnasingham, et al.
Viruses (2024) Vol. 16, Iss. 3, pp. 342-342
Open Access | Times Cited: 9
Targeting the SARS-CoV-2 reservoir in long COVID
Amy D. Proal, Soo Aleman, Morgane Bomsel, et al.
The Lancet Infectious Diseases (2025)
Closed Access | Times Cited: 1
SARS-CoV-2 Spike Protein Is Capable of Inducing Cell–Cell Fusions Independent from Its Receptor ACE2 and This Activity Can Be Impaired by Furin Inhibitors or a Subset of Monoclonal Antibodies
Nina Reuter, Xiaohan Chen, Barbara Kropff, et al.
Viruses (2023) Vol. 15, Iss. 7, pp. 1500-1500
Open Access | Times Cited: 20
Evolution of a globally unique SARS-CoV-2 Spike E484T monoclonal antibody escape mutation in a persistently infected, immunocompromised individual
Peter Halfmann, Nicholas R. Minor, Luis A. Haddock, et al.
Virus Evolution (2022) Vol. 9, Iss. 2
Open Access | Times Cited: 25
Vaccines Alone Cannot Slow the Evolution of SARS-CoV-2
Debra Van Egeren, Madison Stoddard, Laura F. White, et al.
Vaccines (2023) Vol. 11, Iss. 4, pp. 853-853
Open Access | Times Cited: 16
The effects of amino acid substitution of spike protein and genomic recombination on the evolution of SARS-CoV-2
Letian Fang, Jie Xu, Yue Zhao, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 15
Antibody and B Cell Responses to SARS-CoV-2 Infection and Vaccination: The End of the Beginning
Katharina Röltgen, Scott D. Boyd
Annual Review of Pathology Mechanisms of Disease (2023) Vol. 19, Iss. 1, pp. 69-97
Open Access | Times Cited: 15
Chronic COVID-19 infection in an immunosuppressed patient shows changes in lineage over time: a case report
Sheridan J.C. Baker, Landry Nfonsam, Daniela Leto, et al.
Virology Journal (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 5
Persistence of SARS‐CoV‐2 infection and viral intra‐ and inter‐host evolution in COVID‐19 hospitalized patients
Grazia Pavia, Angela Quirino, Nadia Marascio, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 6
Open Access | Times Cited: 5
Viral infections at the animal–human interface—Learning lessons from the SARS‐CoV‐2 pandemic
Harald Brüssow
Microbial Biotechnology (2023) Vol. 16, Iss. 7, pp. 1397-1411
Open Access | Times Cited: 13
COVID-19 relapse associated with SARS-CoV-2 evasion from CD4+ T-cell recognition in an agammaglobulinemia patient
Ryo Morita, Ritsuko Kubota‐Koketsu, Xiuyuan Lu, et al.
iScience (2023) Vol. 26, Iss. 5, pp. 106685-106685
Open Access | Times Cited: 11
CD4 + and CD8 + T cells are required to prevent SARS-CoV-2 persistence in the nasal compartment
Meenakshi Kar, Katherine Johnson, Abigail Vanderheiden, et al.
Science Advances (2024) Vol. 10, Iss. 34
Open Access | Times Cited: 4
Rapid intra-host diversification and evolution of SARS-CoV-2 in advanced HIV infection
Sung Hee Ko, Pierce Radecki, Frida Belinky, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 4
Adaptive evolution of SARS-CoV-2 during a persistent infection for 521 days in an immunocompromised patient
Hanno Schmidt, Luca Aroha Schick, Jürgen Podlech, et al.
npj Genomic Medicine (2025) Vol. 10, Iss. 1
Open Access
Evolutionary Mechanisms of the Emergence of the Variants of Concern of SARS-CoV-2
Igor M. Rouzine
Viruses (2025) Vol. 17, Iss. 2, pp. 197-197
Open Access
SARS-CoV-2 genomic evolution during a severe and long-lasting omicron infection under antiviral therapy
Matteo Bolis, Sara Uceda Renteria, Laura Alagna, et al.
BMC Infectious Diseases (2025) Vol. 25, Iss. 1
Open Access
Variable rates of SARS-CoV-2 evolution in chronic infections
Ewan W. Smith, William L. Hamilton, Ben Warne, et al.
PLoS Pathogens (2025) Vol. 21, Iss. 4, pp. e1013109-e1013109
Open Access
Page 1 - Next Page

Scroll to top